A*STAR
Generated by Llama 3.3-70BExpansion Funnel Raw 128 → Dedup 0 → NER 0 → Enqueued 0
| A*STAR | |
|---|---|
 | |
| Name | A*STAR |
| Headquarters | Biopolis, Singapore |
A*STAR is a Singaporean government agency that promotes innovation and research in science and technology. It was established in 2002 to drive the growth of Singapore's biotechnology and pharmaceutical industries, and has since expanded to include research in materials science, nanotechnology, and information technology. A*STAR works closely with universities such as the National University of Singapore and Nanyang Technological University, as well as with research institutions like the Singapore Institute of Biology and the Institute of Materials Research and Engineering. It also collaborates with industry partners such as GlaxoSmithKline, Pfizer, and Merck.
● Introduction
A*STAR is headquartered in the Biopolis research hub in Singapore, which is also home to other research institutions such as the Bioinformatics Institute and the Genome Institute of Singapore. The agency is led by a board of directors that includes prominent scientists and business leaders such as Tony Tan, Lee Kuan Yew, and Tharman Shanmugaratnam. A*STAR's research focuses on areas such as cancer research, neuroscience, and infectious diseases, and it has established collaborations with institutions such as the National Institutes of Health, the World Health Organization, and the European Molecular Biology Laboratory. A*STAR also works with industry partners such as AstraZeneca, Eli Lilly and Company, and Novartis to develop new therapies and treatments.
● History
A*STAR was established in 2002 as a statutory board under the Ministry of Trade and Industry (Singapore), with the goal of promoting innovation and research in science and technology. The agency was formed through the merger of the National Science and Technology Board and the Institute of Molecular and Cell Biology, and it has since grown to include a range of research institutes and centres. A*STAR has played a key role in the development of Singapore's biotechnology and pharmaceutical industries, and has worked with companies such as Chugai Pharmaceutical, Takeda Pharmaceutical Company, and Roche Holding to establish research and development facilities in Singapore. A*STAR has also collaborated with institutions such as the University of California, Berkeley, the Massachusetts Institute of Technology, and the University of Oxford to advance research in areas such as artificial intelligence, machine learning, and data science.
● Research Institutes
A*STAR has a range of research institutes that focus on areas such as biomedical research, materials science, and information technology. These include the Institute of Materials Research and Engineering, the Data Storage Institute, and the Institute for Infocomm Research, which work with institutions such as the California Institute of Technology, the Carnegie Mellon University, and the University of Cambridge to advance research in areas such as nanotechnology, energy storage, and cybersecurity. A*STAR's research institutes also collaborate with industry partners such as IBM, Microsoft, and Google to develop new technologies and products. Additionally, A*STAR has established partnerships with institutions such as the European Organization for Nuclear Research, the National Aeronautics and Space Administration, and the European Space Agency to advance research in areas such as particle physics, astronomy, and space exploration.
● Education and Training
A*STAR provides a range of education and training programs for students and researchers, including scholarships, fellowships, and internships. These programs are designed to develop the skills and expertise of Singapore's research workforce, and to attract top talent from around the world to work in Singapore's research institutions. A*STAR also collaborates with universities such as the National University of Singapore and Nanyang Technological University to offer graduate programs and research opportunities in areas such as biomedical engineering, computer science, and materials science. A*STAR has also established partnerships with institutions such as the University of Melbourne, the University of Sydney, and the University of Toronto to offer joint degree programs and research collaborations.
● Industry Partnerships
A*STAR has established a range of industry partnerships with companies such as GlaxoSmithKline, Pfizer, and Merck to develop new therapies and treatments. These partnerships involve collaborative research projects, joint development of new products, and licensing of intellectual property. A*STAR also works with small and medium-sized enterprises (SMEs) to provide funding, mentoring, and technical support to help them develop new technologies and products. A*STAR has also established partnerships with institutions such as the Singapore-MIT Alliance for Research and Technology, the Singapore-Stanford Biodesign, and the Singapore-UC Berkeley Initiative for Innovation and Entrepreneurship to advance innovation and entrepreneurship in Singapore.
● Notable Achievements
A*STAR has achieved a range of notable successes in areas such as biomedical research, materials science, and information technology. These include the development of new treatments for diseases such as cancer, diabetes, and Alzheimer's disease, as well as the creation of new materials and technologies with applications in areas such as energy storage, water treatment, and cybersecurity. A*STAR has also established a range of spin-off companies and start-ups that have gone on to become successful businesses in their own right, including companies such as Veredus Laboratories, Innopac Technology, and BioMers. A*STAR has also received numerous awards and recognition for its research and innovation efforts, including the National Science and Technology Award, the President's Science and Technology Award, and the ASEAN Science and Technology Award.